print documentPrint Page

Suboxone Detox Treatment Program
At WellStep Atlanta

Located in Roswell, Georgia (north Atlanta)
Near North Fulton Regional Medical Center

The Suboxone Treatment Program at WellStep Atlanta provides medical detox from prescription opioids (pain pills), heroin and methadone. We also offer maintenance treatment for patients who would like to continue Suboxone for a prolonged period of time.

We are welcoming new patients to our new office in Roswell, Georgia, close to North Fulton Regional Hospital in suburban North Atlanta.

WellStep accepts most insurance PPO's, including Blue Cross Blue Shield and United Health Care and offers affordable self-pay fees for patients not utilizing health insurance.

For more information or to schedule an appointment, please call our office at 770-753-9898.

How SUBOXONE works

1. When opioids attach to the mu receptors, dopamine is released, causing pleasurable feelings to be produced.1,2

2. As opioids leave the receptors, pleasurable feelings fade and withdrawal symptoms (and possibly cravings) begin.1

3. Opioids continue leaving the mu receptors until the person is in a mild-to-moderate state of withdrawal. At this point, SUBOXONE therapy can begin.

4. The primary active ingredient in SUBOXONE-buprenorphine-attaches to the empty opioid receptors, suppressing withdrawal symptoms and reducing cravings.1 As a partial opioid agonist, SUBOXONE works by controlling withdrawal symptoms and cravings and produces a limited euphoria or “high.”1

5. Buprenorphine attaches firmly to the receptors. At adequate maintenance doses, buprenorphine fills most receptors and blocks other opioids from attaching. Buprenorphine has a long duration of action, so its effects do not wear off quickly.

How to Take SUBOXONE

Important SUBOXONE Safety Information


1. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2003;70(suppl 2):S59-S77.

2. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(suppl 2):S13-S27.

For more information, visit